The success of the Phase 3 study reverberated beyond the clinic, sending the company’s shares up more than a third in a ...
The mRNA-based Covid vaccines helped blunt the impact of the pandemic but also sparked political backlash that has threatened ...
Kelonia is developing a next-gen blood cancer treatment that’ll reprogram T-cells to help patients’ immune systems fight ...
Investor's Business Daily on MSN
Eli Lilly snags $7 billion cancer deal to rival Gilead, J&J, others
Eli Lilly said Monday it will spend up to $7 billion to buy privately held Kelonia Therapeutics for its suite of cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results